ロード中...
Oral administration of EP4-selective agonist KAG-308 suppresses mouse knee osteoarthritis development through reduction of chondrocyte hypertrophy and TNF secretion
Osteoarthritis (OA) is one of the world’s most common degenerative diseases, but there is no disease-modifying treatment available. Previous studies have shown that prostaglandin E2 (PGE(2)) and PGE2 receptor 4 (EP(4)) are involved in OA pathogenesis; however, their roles are not fully understood. H...
保存先:
| 出版年: | Sci Rep |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6937271/ https://ncbi.nlm.nih.gov/pubmed/31889132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-56861-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|